The Exchange had sought clarification from Sakar Healthcare Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act. -2. 2013 or as per Indian Accounting Standard. The response of the Company is enclosed.
SAKAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NSE asked Sakar Healthcare to clarify why its financial results for the October-December 2025 quarter did not follow the prescribed format under Schedule III of the Companies Act, 2013 and Indian Accounting Standards (Ind AS). The company has now submitted its response to the exchange, addressing these compliance and presentation-related queries. This is a procedural clarification rather than a penalty or investigation. The core issue appears to be related to how the numbers were reported rather than any accounting irregularity.
No material impact on shareholders or stock price expected, as this is a routine format-related query on financial result presentation. Investors should wait for the next confirmed, fully compliant financial filing for clearer picture of the company's performance.